Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Subscribe to Free Drug Patent Expiration Updates

Also available in a Drug Patent Expiration NewsletterRSS feed and on Drug Patent Expirations on TwitterTwitter

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: RESCRIPTOR

« Back to Dashboard
Rescriptor is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug.

This drug has twenty-one patent family members in twenty countries.

The generic ingredient in RESCRIPTOR is delavirdine mesylate. Two suppliers are listed for this compound. Additional details are available on the delavirdine mesylate profile page.

Summary for Tradename: RESCRIPTOR

Suppliers / Packagers: see list4

Clinical Trials for: RESCRIPTOR

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Viiv Hlthcare
delavirdine mesylate
TABLET;ORAL020705-001Apr 4, 1997RXNo<disabled><disabled>
Viiv Hlthcare
delavirdine mesylate
TABLET;ORAL020705-002Jul 14, 1999RXYes6,177,101<disabled> <disabled>
This preview shows a limited data set
Subscribe for full access

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: RESCRIPTOR

Country Document Number Publication Date
China1301149Jun 27, 2001
Japan2002517430Jun 18, 2002
Brazil9910481Jan 09, 2001
Poland200163Dec 31, 2008
Austria349203Jan 15, 2007
This preview shows a limited data set
Subscribe for full access

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn